# Phase IV Study of rhGH Injection in Adult Short Bowel Syndrome

> **NCT07691125** · PHASE4 · RECRUITING · sponsor: **Changchun GeneScience Pharmaceutical Co., Ltd.** · enrollment: 100 (estimated)

## Conditions studied

- Short Bowel Syndrome (SBS) in Adults

## Interventions

- **BIOLOGICAL:** rhGH injection

## Key facts

- **NCT ID:** NCT07691125
- **Lead sponsor:** Changchun GeneScience Pharmaceutical Co., Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2024-07-31
- **Primary completion:** 2027-04-28
- **Final completion:** 2028-06-10
- **Target enrollment:** 100 (ESTIMATED)
- **Last updated:** 2026-07-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07691125

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07691125, "Phase IV Study of rhGH Injection in Adult Short Bowel Syndrome". Retrieved via MORVS 2026-10-20 from https://api.morvs.ai/clinical/NCT07691125. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*